• Saint George |
  • Cedar City |
  • Mesquite

  • More
  • More
  • More
  • Dixie Techs to feature Dr. Lincoln Nadauld, March 7th
    by kcsg.com news
    Published - 02/28/14 - 12:52 PM | 0 0 comments | 53 53 recommendations | email to a friend | print
    Dr. Lincoln Nadauld
    Dr. Lincoln Nadauld
    slideshow
    (ST. GEORGE, Utah) - Dr. Lincoln Nadauld, Director of Cancer Genomics at Intermountain Healthcare will address the March 7 Tech Friday meeting of the Dixie Technical Association. The meeting will take place at the Dixie State University Taylor Health Science Building Auditorium located at 1526 Medical Center Drive at noon. Dixie Tech members as well as guests are invited. Admission is free and includes a free pizza lunch, but attendees should RSVP by emailing Jared Goodspeed at jgoodspeed@dixie.edu

    Dr. Nadauld received a Bachelor’s Degree in Zoology from Brigham Young University. He went on to complete medical and doctoral degrees (MD/PhD) followed by clinical training at the University of Utah. His doctoral dissertation focused on the molecular genetics of colon cancer. He completed clinical training in Medical Oncology at Stanford University where he also completed a postdoctoral fellowship in solid tumor genomics in the laboratory of Dr. Calvin Kuo.

    Dr. Nadauld then remained on faculty at the Stanford School of Medicine focusing on cancer genomics and personalized cancer medicine. While retaining an adjunct faculty position at Stanford, Dr. Nadauld was recently appointed Director of Cancer Genomics at Intermountain Healthcare, an integrated healthcare system of more than 20 hospitals and 150 clinics, where he is leading the clinical implementation of genomic-based cancer medicine. He is currently based in St. George.

    “We are fortunate to have Dr. Nadauld in southern Utah, and we look forward to having him speak to the Techs,” Joshua Aikens, Dixie Techs chair, said. “It will be interesting, not only to hear him talk about his cutting edge technology, but also hear about his experiences with the big venture capital firms in Silicon Valley.”

    Comments
    (0)
    Comments-icon Post a Comment
    No Comments Yet
    Loading
    Submit an Event